Friday, March 5, 2021

Latest:

Proteomics analysis identifies potential drug targets for aggressive human cancers
Resonance podcast: Clinical education and the art of ballroom dancing
Image of the Month: The laboratory worm, C. elegans
Inspiring hope for a more equitable future in healthcare
Black History Month Spotlight: Interview with Dr. Debra Murray

Baylor College of Medicine Blog Network

Blog Network
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
- About Progress Notes
- Connect With Us
bcm.edu

The Cancer Genome Atlas

From The Labs

Tracking down microRNA candidates that can contribute to disease

November 6, 2018November 6, 2018 Ana Rodríguez 1 Comment ADmiRE, Cancer, developmental disease, gnomAD, heart disease, microRNA, The Cancer Genome Atlas, whole exome sequencing

What started as Ninad Oak’s side project turned out into something much larger, his doctorate thesis. “The project started as my qualifying exam that I

From The Labs

What activates the PI3K pathway, the most commonly mutated pathway in cancer that can be targeted by drugs?

July 31, 2017 Ana Rodríguez 0 Comments cancer mutations, Cancer pathways, IDH1 gene, personalized medicine, PI3K pathway, The Cancer Genome Atlas, VHL gene

The PI3K pathway has a number of diverse functions, including altering the cell’s metabolism and driving cell growth and proliferation. The PI3K pathway also is

From the Labs features an image of the laboratory worm, Caenorhabditis elegans. Image credit: Dr. Tao Chen/Wang lab.